Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease.

Aakash DesaiJessica PetrovJana G HashashHarsh PatelBhaumik BrahmbhattGursimran S KochharFrancis A Farraye

Published in: Alimentary pharmacology & therapeutics (2024)

We found an association between lower risk of IBD-related surgery and GLP-1RA use for T2DM in patients with UC or CD.

Keyphrases